ISRG logo

ISRG
Intuitive Surgical Inc

20,516
Mkt Cap
$150.39B
Volume
3.44M
52W High
$603.88
52W Low
$414.30
PE Ratio
51.51
ISRG Fundamentals
Price
$424.64
Prev Close
$423.63
Open
$424.00
50D MA
$453.94
Beta
1.19
Avg. Volume
2.17M
EPS (Annual)
$7.87
P/B
8.61
Rev/Employee
$591,310.73
$199,772.47
Loading...
Loading...
News
all
press releases
Wall Street Thinks Intuitive Surgical Stock Can Soar Over 30%. Here's Why Analysts are Right.
Key PointsIntuitive Surgical's stock is trading near 52-week lows...
Nasdaq News: Markets
News Placeholder
More News
News Placeholder
TransDigm Group Achieves #91 Analyst Rank, Surpassing Intuitive Surgical
In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, TransDigm Group Inc (Symbol: TDG) has taken over the #91 spot from Intuitive Surgical Inc (Symbol: ISRG), according to ETF Channel. Below is a chart of TransDigm Gro...
Nasdaq News: Markets
News Placeholder
HealthEquity Stock Gains as Q1 Earnings Top Estimates, Revenues Up Y/Y
HQY tops Q1 FY27 EPS and revenue estimates as HSA accounts and assets climb, and guidance for FY27 revenues and adjusted EPS rises.
Zacks
News Placeholder
Natera to Launch Enhanced Panorama NIPT for Low Fetal Fractions
NTRA upgrades Panorama NIPT with SNP-informed deep sequencing, validated for low fetal fraction to cut no-calls and boost reliable prenatal results.
Zacks
News Placeholder
Here is Why Growth Investors Should Buy Intuitive Surgical (ISRG) Now
Intuitive Surgical (ISRG) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Zacks
News Placeholder
Stryker Launches Pangea Plating System in Europe for Fracture Fixation
SYK launches Pangea Plating System in Europe, completing its first London case as it broadens trauma care solutions for many fractures.
Zacks
News Placeholder
Is Intuitive Surgical (ISRG) a Buy as Wall Street Analysts Look Optimistic?
The average brokerage recommendation (ABR) for Intuitive Surgical (ISRG) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Zacks
News Placeholder
ISRG vs. MDT: Which Surgical Robot Stock Is the Better Buy?
ISRG is widening its robotic surgery lead with faster growth, rising procedures and a recurring revenue model as Medtronic builds Hugo.
Zacks
News Placeholder
Here's Why You Should Add BrightSpring Stock to Your Portfolio Now
BTSG leans on surging Specialty & Infusion and integrated home health branches, but IRA and generic shifts may pressure 2026 margins.
Zacks
News Placeholder
Natera Expands Austin Operations With New Sequencing Facility
NTRA is expanding in Austin with what it says will be the world's largest sequencing capacity as oncology testing demand keeps surging.
Zacks
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available